Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Descrição
COLUMBIA, S.C. (April 30, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL). It is part of a 12-product, six-month rollout from Ritedose for hospital pharmacies across the coun
Pfizer 00409178269 - McKesson Medical-Surgical
Labetalol HCI Injection Vial, USP 20 mg/4 mL (5 mg/mL
AbbVie Inc 00074334603 - McKesson Medical-Surgical
The Ritedose Corporation
News – The Ritedose Corporation
News – The Ritedose Corporation
Cardinal 8881570300 - McKesson Medical-Surgical
00409-4264-01 Pfizer Hospital US
Hospira 00409490334 - McKesson Medical-Surgical
de
por adulto (o preço varia de acordo com o tamanho do grupo)